Passage Bio's total assets for Q3 2024 were $111.75M, a decrease of -10.88% from the previous quarter. PASG total liabilities were $39.04M for the fiscal quarter, a 12.06% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.